Molecular and Cellular Mechanisms in Anti-thrombosis
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 32
Special Issue Editors
Interests: cardiovascular pharmacology; protein bio—chemistry; signal transduction; platelet biology; anti-thrombotic drug development
Special Issues, Collections and Topics in MDPI journals
Interests: natural product chemistry; oxidative stress/antioxidant research; environmental toxicology; molecular phytotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cerebrovascular disease is one of the biggest health problems across the globe. Both large and minor cerebral vascular diseases have the potential to cause stroke and to exacerbate the vascular component of other types of neurological disorders. Even while neurovascular illness and the damage that follows ischemia episodes are important, our understanding of neuroprotection and vascular biology in general is still lacking in these areas. Based on the available epidemiological data, coronary heart disease and cerebral hemorrhage were predicted to be the leading causes of mortality for people up to the year 2020. Nevertheless, despite a number of advancements that have aided in our knowledge of illnesses, conventional medicine's use of pharmaceuticals to treat them has not produced satisfying outcomes.
Numerous studies have demonstrated the effectiveness of medication-assisted management of traditional risk factors in lowering cardiovascular events. In addition to using pharmaceuticals to treat cardiovascular risk factors and antithrombotic medications, more people are becoming aware of the potential therapeutic applications of herbal remedies and other natural products as well as their function in the prevention of vascular disorders. Research on the effects of the main risk factors for thrombotic and cerebrovascular illness may open up new avenues for preventing ischemic episodes and enhancing the prognosis of existing patients. Because macrophages and microglia may be important regulators of the blood–brain barrier following stroke. As a result, the goal of this Special Issue was to encourage participation through both original and review papers that would spark long-term efforts to comprehend the pathophysiology behind cerebral–neuro-vascular disorders and to expand on treatment and prevention techniques.
Prof. Dr. Joen-Rong Sheu
Dr. Thanasekaran Jayakumar
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- platelet activation and thrombosis
- neuroprotection
- antithrombotic mechanisms
